Holen Sie sich die Stockscreener-App
5.90
1.20%
0.07
Schlusskurs vom Vortag:
$5.83
Offen:
$5.8
24-Stunden-Volumen:
44,293
Relative Volume:
0.78
Marktkapitalisierung:
$177.31M
Einnahmen:
$8.98M
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-4.403
EPS:
-1.34
Netto-Cashflow:
$-24.83M
1W Leistung:
+3.60%
1M Leistung:
-4.84%
6M Leistung:
-16.31%
1J Leistung:
-43.27%
1-Tages-Spanne:
$5.7749
$6.0404
1-Wochen-Bereich:
$5.54
$6.0404
52-Wochen-Spanne:
$3.895
$11.42
Profound Medical Corp Stock (PROF) Company Profile
Firmenname
Profound Medical Corp
Sektor
Branche
Telefon
647-476-1350
Adresse
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Vergleichen Sie PROF mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.90 | 176.41M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-23 | Eingeleitet | Lake Street | Buy |
| 2024-07-16 | Hochstufung | Stifel | Hold → Buy |
| 2023-11-28 | Eingeleitet | Stifel | Hold |
| 2023-08-04 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-15 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Profound Medical Corp Aktie (PROF) Neueste Nachrichten
(PRN) Technical Patterns and Signals (PRN:CA) - news.stocktradersdaily.com
Should I buy Profound Medical Corp. stock before earningsFree Investment Timing Strategies - jammulinksnews.com
What analysts say about Profound Medical Corp. stockConsistent wealth multiplication - Autocar Professional
Profound Medical to Announce Q2 2025 Financial Results - TipRanks
Profound Medical to Release Second Quarter 2025 Financial Result - GuruFocus
Profound Medical to Release Second Quarter 2025 Financial Results on August 14Conference Call to Follow - The Manila Times
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow - The Spec
Is Profound Medical Corp. stock a growth or value playUnprecedented growth rates - jammulinksnews.com
Is Profound Medical Corp. a good long term investmentBreakneck growth rates - jammulinksnews.com
Profound Medical Corp. Stock Analysis and ForecastPowerful profit generation - jammulinksnews.com
(PRN) Stock Market Analysis (PRN:CA) - news.stocktradersdaily.com
What makes Profound Medical Corp. stock price move sharplyWeekly Double Return List - Newser
What drives Profound Medical Corp. stock priceConsistent triple returns - jammulinksnews.com
MARA Stock Analysis and ForecastMarket-leading growth rates - Jammu Links News
What drives ONIT stock priceHigh-yield investments - Jammu Links News
Why Omega Flex Inc. stock is on top investor watchlistsDaily Stock Radar - Newser
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
How Profound Medical Corp. stock performs during market volatilityFree Stock Trading Signals - Newser
Why Profound Medical Corp. stock attracts strong analyst attentionFree Day Trading Recommendations - Newser
Profound Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (PRN) - The Globe and Mail
(PRN) Dynamic Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical Completes First Commercial BPH Treatment With New TULSA-AI Volume Reduction Module - MSN
(PRN) Trading Strategy and Analysis (PRN:CA) - news.stocktradersdaily.com
Top Companies in Radiation Therapy Devices (Jul, 2025) - Tracxn
Profound Medical's TULSA-AI: Revolutionizing BPH Treatment and Market Expansion - AInvest
(PRN) Stock Trading Blueprint (PRN:CA) - news.stocktradersdaily.com
How To Trade (PRN) (PRN:CA) - news.stocktradersdaily.com
Global Uterine Fibroids Treatment Devices Market is - GlobeNewswire
(PRN) Advanced Equity Analysis (PRN:CA) - news.stocktradersdaily.com
Following a 26% decline over last year, recent gains may please Profound Medical Corp. (TSE:PRN) institutional owners - simplywall.st
Profound Medical (NASDAQ:PROF) Shares Up 17.4% – What’s Next? - Defense World
Regulatory Affairs in Life Sciences - Fasken
Profound Medical (PROF) Advances BPH Treatment with New Module | - GuruFocus
Profound Medical announces first commercial BPH treatment using TULSA-AI - TipRanks
Profound Medical (PROF) Advances BPH Treatment with New Module | PROF Stock News - GuruFocus
Profound Medical Brief: Announcing First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction - MarketScreener
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction - Yahoo Finance
(PRN) Trading Performance and Risk Management (PRN:CA) - news.stocktradersdaily.com
Learn to Evaluate (PRN) using the Charts (PRN:CA) - news.stocktradersdaily.com
Profound Medical (PROF) Partners with Leonard Wheeler to Boost T - GuruFocus
Profound Medical (PROF) Partners with Leonard Wheeler to Boost TULSA-PRO Awareness | PROF Stock News - GuruFocus
Profound Medical Partners with NFL Legend Leonard Wheeler to Promote TULSA-PRO - TipRanks
Profound Medical enters agreement with former NFL player Leonard Wheeler - TipRanks
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassado - GuruFocus
Finanzdaten der Profound Medical Corp-Aktie (PROF)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):